Cargando…
Attenuated Disease in SIV-Infected Macaques Treated with a Monoclonal Antibody against FasL
Acute SIVmac infection in macaques is accompanied by high levels of plasma viremia that decline with the appearance of viral immunity and is a model for acute HIV disease in man. Despite specific immune responses, the virus establishes a chronic, persistent infection. The destruction of CD4+ and CD4...
Autores principales: | Salvato, Maria S., Yin, C. Cameron, Yagita, Hideo, Maeda, Toshihiro, Okumura, Ko, Tikhonov, Ilia, Pauza, C. David |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2248700/ https://www.ncbi.nlm.nih.gov/pubmed/18317535 http://dx.doi.org/10.1155/2007/93462 |
Ejemplares similares
-
Role of the Fas/FasL pathway in HIV or SIV disease
por: Poonia, Bhawna, et al.
Publicado: (2009) -
Modulation of SIV and HIV DNA Vaccine Immunity by Fas-FasL Signaling
por: Yan, Jiabin, et al.
Publicado: (2015) -
The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability
por: Henkler, Frank, et al.
Publicado: (2005) -
Expansion of FasL-Expressing CD5(+) B Cells in Type 1 Diabetes Patients
por: Saxena, Ankit, et al.
Publicado: (2017) -
Systemic FasL and TRAIL Neutralisation Reduce Leishmaniasis Induced Skin Ulceration
por: Tasew, Geremew, et al.
Publicado: (2010)